Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94115


Patients with neovascular Age-related macular degeneration (AMD) and the particular feature of pigment epithelial detachments (PEDs) were not studied in the Phase III trials for ranibizumab (Lucentis). The PrONTO study was the first ranibizumab study to enroll such patients but only treated with ranibizumab until fluid within the layers of the retina was absent, not until the entire PED was absent. This study hypothesizes that there may be a difference in benefit between patients treated until just the retinal edema is gone and those in which the retinal edema and PED are both gone.


Inclusion Criteria: - Neovascular age-related macular degeneration patients over age 50 - Presence of a pigment epithelial detachment on optical coherence tomography - Initial or recurrent disease - Previous treatment allowed - Visual acuity between Snellen 20/40 - 20/400 Exclusion Criteria: - More than three previous treatments with PDT or other radiation/laser therapy - Previous vitrectomy or other AMD surgical intervention - Severe scarring or severe concurrent ocular disease (uncontrolled glaucoma) Patients eligible for the study are randomized into one of two groups. Group 1 receives injections of ranibizumab until retinal edema is resolved. Group 2 receives ranibizumab injections until both retinal edema and the PED are resolved. Study duration is one year with visits once per month.



Primary Contact:

Principal Investigator
Anne Fung, MD
Pacific Eye Associates / California Pacific Medical Center

Backup Contact:


Location Contact:

San Francisco, California 94115
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.